This site is intended for health professionals only!

Published on 23 November 2011

Share this story:
Twitter
LinkedIn
Share
RELATED ARTICLES
Improving short-term PCI microperfusion
Doctors warn of “TB time bomb”
Assessment of safety profile of Stelara® for moderate to severe psoriasis
Accord Healthcare case successfully resolved
Glaxo set to sell Wellbutrin XL brand

Understanding compassionate-use programmes

teaser

 

Prof Paola Minghetti, PhD  

Professor of Pharmaceutical Sciences, Universit



Most read

1
Feedback: Automation systems in your hospital
2
Helapet introduce new, improved 20mm Vented Vial Adapter
3
Janssen-Cilag’s Stelara approved by NICE
4
Merck agrees huge Vioxx settlement
5
Encouraging results for SLE treatment



Latest Issue

Read the latest issue >
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
Share this story:
Twitter
LinkedIn
Share
RELATED ARTICLES
UCB to divest Equasym
Professional practice in a changing environment
Evolva announces change in management team
FDA approval of Rebif Rebidose
PA21 authorisation application submitted in Switzerland